Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | HTR1D | P28221 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | HTR3A | P46098 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28867385 | 0.77 | TAAR1 (0.51) | TAAR1ALDH1A1HTR2CHTR2B | |
| SCHEMBL20385738 | 0.77 | TAAR1 (0.51) | TAAR1ALDH1A1HTR2CHTR2B | |
| SCHEMBL25440356 | 0.71 | KDM1A (0.47) | KDM4EALDH1A1MAPTHPGDNPSR1 | |
| SCHEMBL8055813 | 0.69 | TAAR1 (0.46) | TAAR1ALDH1A1MAPTHSD17B10HTR2C | |
| SCHEMBL500727 | 0.69 | TAAR1 (0.46) | TAAR1ALDH1A1MAPTHSD17B10HTR2C | |
| SCHEMBL3354178 | 0.69 | TAAR1 (0.46) | TAAR1ALDH1A1MAPTHSD17B10HTR2C | |
| SCHEMBL14290407 | 0.66 | PDPK1 (0.44) | KDM4EPOLBUSP2ALDH1A1MAPT | |
| SCHEMBL12650555 | 0.66 | KDM4E (0.38) | KDM4EPOLBUSP2ALDH1A1MAPT | |
| SCHEMBL12324058 | 0.66 | SLC6A2 (0.39) | TAAR1KDM4EPOLBUSP2ALDH1A1 | |
| SCHEMBL1133317 | 0.65 | SMN1; SMN2 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010018516-A1 | Oxazoline or oxazine acetoacetate aqueous coating compositions | BASF CORPORATION | 2001-08-30 | — | — | US | disclosed |
| US-6235901-B1 | CAN BE POLYMERIZED AND/OR COPOLYMERIZED BY CATONIC POLYMERIZATION; CAN BE CROSSLINKED AND ARE USEFUL IN COATINGS, INKS, OVERPRINT VARNISHES, AND SURFACE TREATMENT APPLICATIONS. | S. C. JOHNSON COMMERCIAL MARKETS, INC. | 2001-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010018516-A1 | Oxazoline or oxazine acetoacetate aqueous coating compositions | ITGB7, DNMT3A, KAT7 | TAAR1 171/4885KDM4E 567/4885POLB 520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.